Chronic pain education: past, present, and future of psychedelics for the management of chronic pain - Takeaways - MDSpire

Chronic pain education: past, present, and future of psychedelics for the management of chronic pain

  • By

  • Christopher L Robinson

  • Pawan K Solanki

  • Sean Snyder

  • Adam Amir

  • Antje Barreveld

  • Rory Vu Mather

  • Ivo H Cerda

  • Michael Motoc

  • Harman Chopra

  • Robert Jason Yong

  • Joel Castellanos

  • Timothy Furnish

  • Alan D Kaye

  • Vwaire Orhurhu

  • Trent Emerick

  • December 10, 2024

  • 0 min

Share

  • 1

    Psychedelics are being explored for therapeutic applications in chronic pain management and mental health conditions.

  • 2

    Recent FDA recognition and changing legislation are driving renewed interest in psychedelics for medical use.

  • 3

    Psychedelics act as 5HT2A receptor partial agonists, influencing mood and perception through neural circuit disruption.

  • 4

    There is a growing call for integrating psychedelic education into medical curricula to prepare future clinicians.

  • 5

    Ethical, legal, and cultural complexities pose significant barriers to the inclusion of psychedelics in formal medical training.

Original Source(s)

Chronic pain education: past, present, and future of psychedelics for the management of chronic pain

  • by Christopher L Robinson, Pawan K Solanki, Sean Snyder, Adam Amir, Antje Barreveld, Rory Vu Mather, Ivo H Cerda, Michael Motoc, Harman Chopra, Robert Jason Yong, Joel Castellanos, Timothy Furnish, Alan D Kaye, Vwaire Orhurhu, Trent Emerick

  • December 10, 2024

Related Content

Side Effects: Turns Out, Never Mind

Red meat didn't wreck the pancreas. Sauna doesn't do what we thought. Loneliness doesn't accelerate decline. A week of quietly overturned assumptions.

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Response to: The Role of Intraoperative Sodium Oxybate in Reducing Post-Operative Delirium Among Elderly Patients in Major Orthopedic Procedures